×

To enhance security, Multi-Factor Authentication (MFA) is mandatory for all HL7 users. More information

Section 1c: FHIR®
Section 3: Implementation Guides

HL7 FHIR® Implementation Guide: Central Cancer Registry Reporting Content IG, Edition 1- US Realm

DESCRIPTION

The MedMorph Central Cancer Registry Reporting Content IG specifies how the MedMorph RA IG is leveraged to enable health care organizations to implement Central Cancer Reporting Use Cases. This standard facilitates automated, standardized exchange of cancer surveillance data from ambulatory healthcare provider EHR systems to central cancer registries. The IG leverages existing technology frameworks and standards (e.g., minimal Common Oncology Data Elements (mCODE)), facilitates automated electronic collection and exchange, reduces reporting burden on data providers, augments secure transfers, and enhances data completeness, timeliness, and accuracy of cancer surveillance data using modern IT standards.

See the specification at http://hl7.org/fhir/us/central-cancer-registry-reporting/STU1

ALTERNATIVE NAMES

HL7 FHIR® Implementation Guide: Central Cancer Registry Reporting Content IG, Edition 1- US Realm may also go by the following names or acronyms:

"HL7 FHIR® IG: MedMorph Cancer, R1",

BENEFITS

  • Provides guidance to transmit cancer case information to state central cancer registries. Access is provided to data not currently available, or available through non-standard and/or manual methods; it will not replace hospital registry reporting methods that are working well. 
  • Assesses how to address the gaps in workflow and triggers, and the ability to leverage MedMorph RA IG along with other existing HL7 FHIR® Implementation Guides to address the public health information needs.

IMPLEMENTATIONS/CASE STUDIES

  • MITRE (CodeX)

DEVELOPMENT BACKGROUND

The HL7 FHIR Standard has been used by healthcare application implementers across the globe, drawn by its ease of use. FHIR is a landmark step to remove many of the barriers to healthcare data exchange.

RELATED DOCUMENTS

HL7 FHIR® Implementation Guide: Central Cancer Registry Reporting Content IG, Edition 1- US Realm

STU DOCUMENTS

HL7 FHIR® Implementation Guide: Central Cancer Registry Reporting Content IG, Edition 1- US Realm See the standard at http://hl7.org/fhir/us/central-cancer-registry-reporting/STU1. Expiration May 2026

TOPIC

  • Public Health

BALLOT TYPE

  • STU

STATUS DATE

2024-05-31

RESPONSIBLE WORK GROUP

Public Health

PRODUCT TYPE

  • Implementation Guide

STAKEHOLDERS

  • Clinical and Public Health Laboratories
  • EHR, PHR Vendors
  • Healthcare Institutions
  • Local and State Departments of Health
  • Standards Development Organizations (SDOs)

FAMILY

  • FHIR

CURRENT STATE

  • Active

REALM

  • US Realm